Table 1.
Demographic and clinical characteristics of the participants.
| Schizophrenia (n = 42) | Control subjects (n = 42) | |
|---|---|---|
| Male/female | 29/13 | 29/13 |
| Age (years) | 26.1 (6.8) | 26.2 (5.9) |
| Education (years) | 11.0 (2.7) | 10.9 (2.5) |
| Body mass index (BMI) | 23.2 (4.1) | 22.7 (4.3) |
| Waist-to-hip ratio | 0.79 (0.12) | t1: 0.79 (0.13) |
| Smokers/non-smokers | 22/20 | 22/20 |
| Positive and Negative Syndrome Scale (PANSS) | ||
| Positive symptoms | 19.4 (7.9) | |
| Negative symptoms | 13.5 (7.0) | |
| General symptoms | 56.3 (17.1) | |
Data are mean (standard deviations) except for male/female and smokers/non-smokers ratios. There were no significant differences between schizophrenia patients and control subjects as revealed by t-tests (for means/SD) and chi-square tests (for distributions) (p > 0.2).